MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Cortical phase amplitude coupling (PAC) identifies patterns in clinical states of Parkinson’s disease (PD) using magnetoencephalography (MEG)

    E. Peña, S.A. Mian, L. Rosedahl, F.A.I. Mohammed, T.M. Mohammad, M.D. Johnson, J.A. Bajwa (Minneapolis, MN, USA)

    Objective: To apply pattern recognition algorithms to identify changes in cortical phase amplitude coupling (PAC) responses derived from PD subjects while off and on levodopa/carbidopa…
  • 2016 International Congress

    Neuromelanin-MRI of substantia nigra subregions in Parkinson’s disease

    L. Borellini, G. Franco, P. Trujillo, P. Summers, A. Di Fonzo, D.O. Claassen, A. Costa (Milan, Italy)

    Objective: To detect changes in the different subregions of the substantia nigra pars compacta (SNc) in patients with Parkinson's disease (PD) and to correlate the…
  • 2016 International Congress

    Effects of zonisamide on dementia with Lewy bodies (DLB): A post-hoc analysis of phase 2 study for parkinsonism in DLB patients

    M. Murata, M. Nakamura, H. Maruyama (Tokyo, Japan)

    Objective: To clarify the effects of zonisamide (ZNS) on the core symptoms of dementia with Lewy bodies (DLB), we performed a post-hoc analysis using data…
  • 2016 International Congress

    Parkinson’s disease patients with onset in right side have a worse cognitive prognosis

    T. Poliakova, I. Zerr, O. Levin (Belgorod, Russia)

    Objective: The our intention was to investigate a dynamics of cognitive decline in patients with different side of onset parkinsonism in view of visual dysfunction…
  • 2016 International Congress

    Neuron specific protein S100B and cognitive impairment in various forms parkinsonism

    R.J. Matmurodov, K.M. Khalimova, N.S. Rashidova, U. Ergashev, O. Turgunhojayev (Tashkent, Uzbekistan)

    Objective: In Parkinson's disease (PD) in almost all patients at the early stages of developing cognitive impairment. Background: Study of the degree of cognitive impairment,…
  • 2016 International Congress

    Speech prosody impairment predicts cognitive decline in Parkinson’s disease

    I. Rektorova, J. Mekyska, E. Janousova, M. Kostalova, M. Mrackova, I. Eliasova, D. Berankova, R. Marecek (Brno, Czech Republic)

    Objective: We assessed whether baseline speech prosodic parameters, alone or in combination with other predominantly non-dopaminergic symptoms may predict global cognitive decline as measured by…
  • 2016 International Congress

    Effects of a 12-week exercise program on cognition in Parkinson’s disease

    J.C. Johnson, A.L. Svitak, M.T. Farrell, S.C. Mosch, F. Yu, E.D. Parker, L.R. Hanson (Saint Paul, MN, USA)

    Objective: To evaluate the effectiveness of a 12-week vigorous exercise program to improve primarily cognition and secondarily motor function and quality of life in patients…
  • 2016 International Congress

    Mild cognitive impairment in Parkinson’s disease: Impact on caregiver outcomes

    J.Y.Y. Szeto, M. Gilat, C.C. Walton, L. Mowszowski, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

    Objective: To utilise the newly established the International Parkinson and Movement Disorder Society (MDS) Task Force diagnostic criteria for Mild Cognitive Impairment (MCI) in Parkinson's…
  • 2016 International Congress

    Mild cognitive impairment is linked with white matter degeneration in the cortico-subcortical tracts in patients with Parkinson’s disease

    A. Hanganu, J.C. Houde, V.S. Fonov, C. Degroot, B. Mejia-Constain, A.L. Lafontaine, V. Soland, S. Chouinard, L.D. Collins, M. Descoteaux, O. Monchi (Calgary, Canada)

    Objective: Evaluate the correlation between brain tractography changes in patients with Parkinson's disease (PD) with and without mild cognitive impairment (MCI). Background: Up to 40%…
  • 2016 International Congress

    Consolidation of learning and memory in Parkinson’s disease

    M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy (New York City, NY, USA)

    Objective: To determine if Parkinson's disease causes an impairment in the ability to consolidate learning into long-term memory and to determine if this deficit is…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • #25179 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley